Low-Grade Gliomas: Evidence-Based Treatment Options

  • Frederick F. Lang
Part of the M. D. Anderson Cancer Care Series book series (MDCCS)


Total Resection Pilocytic Astrocytoma Suprasellar Region Anaplastic Oligodendrogliomas Fibrillary Astrocytoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Berger, MS, Deliganis AV, Dobbins J, Keles GE. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 1994;74:1784–1791.PubMedCrossRefGoogle Scholar
  2. Bernstein M, Guha A. Biopsy of low-grade astrocytomas. J Neurosurg 1994;80: 776–777.PubMedGoogle Scholar
  3. Cairncross G, Berkey B, Shaw E, et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 2006;24:2707–2714.PubMedCrossRefGoogle Scholar
  4. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473–1479.PubMedCrossRefGoogle Scholar
  5. Central Brain Tumor Registry of the United States. Statistical Report: Primary Brain Tumors in the United States, 1998–2002. Central Brain Tumor Registry of the United States; 2005.Google Scholar
  6. Daumas-Duport C, Scheithauer BW, Kelly PJ. A histologic and cytologic method for the spatial definition of gliomas. Mayo Clin Proc 1987;62:435–449.PubMedGoogle Scholar
  7. Fernandez C, Figarella-Branger D, Girard N, et al. Pilocytic astrocytomas in children: prognostic factors—a retrospective study of 80 cases. Neurosurgery 2003;53:544–553; discussion 554–555.PubMedCrossRefGoogle Scholar
  8. Jackson R, Fuller G, Abi-Said D, et al. Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-Oncology 2001;3:193–200.PubMedCrossRefGoogle Scholar
  9. Jaeckle KA, Ballman KV, Rao RD, Jenkins RB, Buckner JC. Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response. J Clin Oncol 2006;24:1246–1252.PubMedCrossRefGoogle Scholar
  10. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 2002;52:316–324.PubMedGoogle Scholar
  11. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Radiat Oncol Biol Phys 1996;36:549–556.PubMedGoogle Scholar
  12. Kleihues P, Cavenee WK. Pathology and Genetics of Tumors of the Nervous System. Lyon, France: IARC Press: 2000.Google Scholar
  13. Lang FF, Gilbert MR. Diffusely infiltrative low-grade gliomas in adults. J Clin Oncol 2006;24:1236–1245.PubMedCrossRefGoogle Scholar
  14. Levin VA, Edwards MS, Wright DC, et al. Modified procarbazine, CCNU, and vincristine (PCV 3) combination chemotherapy in the treatment of malignant brain tumors. Cancer Treat Rep 1980;64:237–244.PubMedGoogle Scholar
  15. Pignatti F, van den Bent M, Curran D, et al. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076–2084.PubMedCrossRefGoogle Scholar
  16. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20:2267–2276.PubMedCrossRefGoogle Scholar
  17. Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006;7:392–401.PubMedCrossRefGoogle Scholar
  18. van den Bent MJ, Afra D, de Witte O, et al. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 2005;366:985–990.PubMedCrossRefGoogle Scholar
  19. van den Bent MJ, Carpentier AF, Barndes AA, et al. Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 2006;24:2715–2722.PubMedCrossRefGoogle Scholar
  20. Vuorinen V, Hinkka S, Färkkilä M, Jääskeläinen J. Debulking or biopsy of malignant glioma in elderly people—a randomised study. Acta Neurochir (Wien) 2003;145:5–10.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Frederick F. Lang

There are no affiliations available

Personalised recommendations